Two Sigma Advisers’s Quest Diagnostics DGX Stock Holding History

Two Sigma Advisers’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,700	Closed	-$295K	–	591
2025 Q4	$295K	Buy	+1,700	New	+$310K	﹤0.01%	1986
2024 Q2	–	Sell	-52,000	Closed	-$6.92M	–	2496
2024 Q1	$6.92M	Buy	+52,000	New	+$6.75M	0.02%	648
2023 Q2	–	Sell	-17,800	Closed	-$2.52M	–	2445
2023 Q1	$2.52M	Sell	17,800 -17,400	-49%	-$2.49M	0.01%	1160
2022 Q4	$5.51M	Sell	35,200 -17,600	-33%	-$2.53M	0.02%	744
2022 Q3	$6.48M	Sell	52,800 -46,000	-47%	-$6.06M	0.02%	634
2022 Q2	$13.1M	Buy	98,800 +22,700	+30%	+$3.09M	0.04%	435
2022 Q1	$10.4M	Buy	76,100 +22,200	+41%	+$3.09M	0.03%	506
2021 Q4	$9.32M	Sell	53,900 -147,200	-73%	-$22.4M	0.02%	519
2021 Q3	$29.2M	Sell	201,100 -383,900	-66%	-$56.2M	0.08%	238
2021 Q2	$77.2M	Buy	585,000 +106,200	+22%	+$13.9M	0.2%	101
2021 Q1	$61.4M	Buy	478,800 +84,700	+21%	+$10.4M	0.17%	124
2020 Q4	$47M	Sell	394,100 -85,300	-18%	-$10.4M	0.13%	179
2020 Q3	$54.9M	Sell	479,400 -84,900	-15%	-$10M	0.16%	138
2020 Q2	$64.3M	Buy	564,300 +94,500	+20%	+$10M	0.19%	117
2020 Q1	$37.7M	Sell	469,800 -30,500	-6%	-$3.16M	0.14%	160
2019 Q4	$53.4M	Sell	500,300 -62,200	-11%	-$6.49M	0.12%	188
2019 Q3	$60.2M	Buy	562,500 +26,704	+5%	+$2.74M	0.15%	165
2019 Q2	$54.5M	Sell	535,796 -606,400	-53%	-$58.3M	0.14%	188
2019 Q1	$103M	Sell	1,142,196 -78,300	-6%	-$6.78M	0.26%	93
2018 Q4	$102M	Buy	1,220,496 +493,200	+68%	+$46.2M	0.28%	94
2018 Q3	$78.5M	Sell	727,296 -1,000	-0.1%	-$110K	0.19%	142
2018 Q2	$80.1M	Buy	728,296 +20,100	+3%	+$2.09M	0.22%	123
2018 Q1	$71M	Buy	708,196 +228,075	+48%	+$23.4M	0.19%	145
2017 Q4	$47.3M	Buy	480,121 +82,425	+21%	+$7.81M	0.13%	202
2017 Q3	$37.2M	Sell	397,696 -110,464	-22%	-$11.7M	0.11%	236
2017 Q2	$56.5M	Buy	508,160 +197,864	+64%	+$20.9M	0.19%	143
2017 Q1	$30.5M	Buy	310,296 +262,300	+547%	+$25M	0.1%	254
2016 Q4	$4.41M	Buy	47,996 +37,800	+371%	+$3.26M	0.02%	793
2016 Q3	$863K	Buy	+10,196	New	+$856K	﹤0.01%	1426
2015 Q2	–	Sell	-73,396	Closed	-$5.64M	–	1930
2015 Q1	$5.64M	Buy	+73,396	New	+$5.26M	0.04%	459
2014 Q3	–	Sell	-4,896	Closed	-$302K	–	2401
2014 Q2	$287K	Sell	4,896 -1,500	-23%	-$87.8K	﹤0.01%	2036
2014 Q1	$371K	Sell	6,396 -44,900	-88%	-$2.41M	﹤0.01%	1739
2013 Q4	$2.75M	Buy	51,296 +42,600	+490%	+$2.53M	0.03%	600
2013 Q3	$537K	Buy	+8,696	New	+$520K	0.01%	1331

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Two Sigma Advisers's DGX Position: Q1 2026 in Review

Two Sigma Advisers sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 1,700 shares — an estimated $295K sold.

Two Sigma Advisers first reported a position in DGX in Q3 2013 and held it in 34 quarters. The position peaked at $103M in Q1 2019. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Two Sigma Advisers reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 1,700 Quest Diagnostics shares in Q1 2026, an estimated $295K.
Two Sigma Advisers first reported a position in Quest Diagnostics in Q3 2013 and held it in 34 quarters.
Two Sigma Advisers's Quest Diagnostics position peaked at $103M in Q1 2019.
1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.